News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
856,392 Results
Type
Article (87121)
Company Profile (704)
Press Release (768547)
Multimedia
Podcasts (159)
Webinars (21)
Section
Business (232935)
Career Advice (4136)
Deals (39774)
Drug Delivery (132)
Drug Development (91164)
Employer Resources (200)
FDA (18231)
Job Trends (17378)
News (397089)
Policy (39872)
Tag
Academia (3002)
Academic (2)
Accelerated approval (16)
Adcomms (33)
Allergies (111)
Alliances (56978)
ALS (129)
Alzheimer's disease (1628)
Antibody-drug conjugate (ADC) (197)
Approvals (18209)
Artificial intelligence (433)
Autoimmune disease (39)
Automation (22)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (143)
Biotechnology (482)
Bladder cancer (110)
Brain cancer (45)
Breast cancer (420)
Cancer (3369)
Cardiovascular disease (273)
Career advice (3546)
Career pathing (34)
CAR-T (222)
CDC (43)
Cell therapy (611)
Cervical cancer (27)
Clinical research (74702)
Collaboration (1213)
Company closure (4)
Compensation (806)
Complete response letters (44)
COVID-19 (2926)
CRISPR (72)
C-suite (446)
Cystic fibrosis (128)
Data (3449)
Decentralized trials (2)
Denatured (57)
Depression (88)
Diabetes (396)
Diagnostics (7022)
Digital health (27)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (201)
Drug pricing (168)
Drug shortages (36)
Duchenne muscular dystrophy (174)
Earnings (98576)
Editorial (51)
Employer branding (25)
Employer resources (169)
Events (131925)
Executive appointments (938)
FDA (20352)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1084)
Gene editing (155)
Generative AI (43)
Gene therapy (482)
GLP-1 (976)
Government (5324)
Grass and pollen (7)
Guidances (327)
Healthcare (20930)
HIV (47)
Huntington's disease (32)
IgA nephropathy (48)
Immunology and inflammation (201)
Immuno-oncology (17)
Indications (44)
Infectious disease (3136)
Inflammatory bowel disease (173)
Inflation Reduction Act (13)
Influenza (83)
Intellectual property (148)
Interviews (813)
IPO (17915)
IRA (59)
Job creations (5194)
Job search strategy (2863)
Kidney cancer (15)
Labor market (65)
Layoffs (614)
Leadership (29)
Legal (10143)
Liver cancer (88)
Longevity (12)
Lung cancer (471)
Lymphoma (240)
Machine learning (17)
Management (65)
Manufacturing (519)
MASH (113)
Medical device (14793)
Medtech (14806)
Mergers & acquisitions (22647)
Metabolic disorders (1023)
Multiple sclerosis (108)
NASH (23)
Neurodegenerative disease (168)
Neuropsychiatric disorders (48)
Neuroscience (2466)
NextGen: Class of 2025 (7687)
Non-profit (5094)
Now hiring (53)
Obesity (516)
Opinion (300)
Ovarian cancer (110)
Pain (139)
Pancreatic cancer (139)
Parkinson's disease (210)
Partnered (27)
Patents (367)
Patient recruitment (229)
Peanut (55)
People (65930)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (23041)
Phase II (32431)
Phase III (24422)
Pipeline (2324)
Policy (270)
Postmarket research (3554)
Preclinical (10402)
Press Release (72)
Prostate cancer (164)
Psychedelics (47)
Radiopharmaceuticals (279)
Rare diseases (577)
Real estate (7404)
Recruiting (76)
Regulatory (27514)
Reports (64)
Research institute (2668)
Resumes & cover letters (650)
Rett syndrome (11)
RNA editing (14)
RSV (62)
Schizophrenia (113)
Series A (180)
Series B (130)
Service/supplier (30)
Sickle cell disease (73)
Special edition (23)
Spinal muscular atrophy (168)
Sponsored (38)
Startups (4313)
State (2)
Stomach cancer (17)
Supply chain (89)
Tariffs (81)
The Weekly (100)
Vaccines (979)
Venture capital (62)
Weight loss (356)
Women's health (54)
Worklife (20)
Date
Today (140)
Last 7 days (492)
Last 30 days (2737)
Last 365 days (34069)
2025 (21931)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (75)
Alaska (7)
Arizona (289)
Arkansas (14)
Asia (50698)
Australia (8907)
California (8523)
Canada (2602)
China (791)
Colorado (364)
Connecticut (381)
Delaware (232)
Europe (116401)
Florida (1276)
Georgia (294)
Hawaii (3)
Idaho (67)
Illinois (775)
India (39)
Indiana (416)
Iowa (19)
Japan (255)
Kansas (120)
Kentucky (34)
Louisiana (20)
Maine (75)
Maryland (1181)
Massachusetts (6472)
Michigan (290)
Minnesota (526)
Mississippi (4)
Missouri (109)
Montana (32)
Nebraska (26)
Nevada (96)
New Hampshire (75)
New Jersey (2358)
New Mexico (31)
New York (2337)
North Carolina (1318)
North Dakota (10)
Northern California (3756)
Ohio (272)
Oklahoma (17)
Oregon (49)
Pennsylvania (1807)
Puerto Rico (18)
Rhode Island (42)
South America (1654)
South Carolina (42)
South Dakota (1)
Southern California (3207)
Tennessee (138)
Texas (1336)
United States (31880)
Utah (254)
Virginia (231)
Washington D.C. (81)
Washington State (735)
West Virginia (4)
Wisconsin (89)
There are 856,392 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BioVersys Receives EMA Orphan Designation for the Combination of Alpibectir and Ethionamide for the Treatment of Tuberculosis
August 27, 2025
·
7 min read
C-suite
With Political Disarray at an All-Time High, the Pharma CEO Chair Is a Lonely Gig
As the political winds shift on a whim and public distrust of the pharma industry reaches fever pitch over drug pricing, executives are being asked to navigate an impassible path.
August 27, 2025
·
7 min read
·
Annalee Armstrong
Press Releases
Vivoryon Therapeutics N.V. to Report H1 2025 Financial Results and Operational Progress on September 4, 2025
August 27, 2025
·
3 min read
Press Releases
Idorsia successfully completes convertible bonds restructuring
August 27, 2025
·
6 min read
Press Releases
IRLAB Publishes Interim Report for the Period January - June 2025
August 27, 2025
·
9 min read
Press Releases
Faron Pharmaceuticals Ltd: Half-Year Financial Results 1 January - 30 June 2025
August 27, 2025
·
14 min read
Press Releases
Cantargia Granted Important US Patent for Nadunolimab
August 27, 2025
·
3 min read
Press Releases
Keymed Biosciences (02162.HK) Reports Strong Interim 2025 Results with Accelerated Commercialization and Robust R&D Momentum
August 27, 2025
·
1 min read
Press Releases
BriaCell’s Bria-OTS+™ Mechanism of Action Validated in Highly Rated Peer Reviewed Cancer Journal
August 27, 2025
·
4 min read
Press Releases
Altimmune to Participate in Upcoming September 2025 Investor Conferences
August 27, 2025
·
1 min read
1 of 85,640
Next
